Who Decides What Gets Studied? The Publishing Giants Quietly Shaping America's Research Agenda

When most people imagine the forces shaping American scientific research, they picture federal funding agencies, university administrators, or perhaps the private sector interests of pharmaceutical and technology companies. Rarely does anyone point to a handful of Amsterdam- and Berlin-headquartered publishing conglomerates. Yet the evidence increasingly suggests that a concentrated oligopoly of academic publishers exercises influence over the direction of American science that is both profound and largely invisible to the public.

Elsevier, Springer Nature, and Wiley—along with a few smaller players—collectively control somewhere between 50 and 60 percent of all peer-reviewed academic journal output globally. In certain disciplines, their market share climbs considerably higher. This is not simply a commercial curiosity. It is a structural feature of the knowledge economy that shapes what research gets conducted, what findings receive amplification, and which scientific questions are quietly left unanswered.

The Prestige Pipeline and Its Hidden Costs

Academic careers in the United States are built on publication records, and publication records are evaluated—formally or informally—by journal prestige. Tenure committees, grant review panels, and hiring boards all rely on proxies like journal impact factors and institutional rankings that disproportionately reward placement in publications owned by the major commercial publishers. A paper published in an Elsevier flagship journal carries a different professional weight than the same work published in a smaller independent or open-access venue, regardless of the research's actual merit or societal value.

This creates a feedback loop with significant consequences. Researchers, particularly early-career scientists who cannot afford professional risk, are incentivized to pursue questions that fit the editorial preferences of high-impact journals. Topics perceived as niche, politically sensitive, or commercially unattractive face a steeper climb toward the prestige that unlocks further funding. Over time, the aggregate effect of thousands of individual career calculations quietly bends the arc of American science toward certain questions and away from others.

Researchers working in underfunded areas—rural health disparities, neglected tropical diseases with no significant US market, environmental justice in low-income communities—frequently describe encountering a ceiling. Their work may be methodologically rigorous and socially urgent, yet it struggles to find placement in the journals that would translate into the grant funding necessary to continue it.

Structural Incentives as a Filter on Knowledge

The problem is not that individual editors at major publishers are consciously suppressing important research. The problem is structural. Commercial publishers are accountable to shareholders and subscription revenue, not to the public interest priorities that nominally guide federally funded science. Their editorial strategies, however professionally managed, are not designed to ensure that the full spectrum of human need is reflected in the research literature.

Consider the geography of research attention. Studies examining health outcomes in rural Appalachia, agricultural sustainability in the Midwest, or educational interventions in under-resourced urban school districts rarely generate the citation volumes that inflate impact factors. High-citation research tends to cluster in areas where large, well-funded research communities already exist—which means the prestigious journals that depend on citation metrics are structurally biased toward already-dominant fields and institutions.

This is compounded by what some scholars have called the "citation cartel" dynamic: a pattern in which journals within the same publishing house cite one another at elevated rates, artificially bolstering impact metrics and reinforcing the prestige hierarchy that keeps their titles at the top of the rankings. Several analyses of citation networks in biomedical and social science literature have documented statistically anomalous within-portfolio citation clustering among the major publishers' journal families.

The Funding Connection

The relationship between journal prestige and research funding is not merely correlational. Major federal funders, including the National Institutes of Health and the National Science Foundation, rely on peer review panels composed of researchers whose own professional standing has been shaped by the same prestige hierarchy. Grant applications that propose work in areas with strong representation in high-impact journals benefit from reviewers who are intellectually and professionally familiar with those research traditions. Applications in underrepresented areas face reviewers who may be less equipped to evaluate their significance.

Private foundations and industry funders, which have grown considerably as a share of total US research funding over the past two decades, apply their own filters—often more explicitly commercial—that further concentrate research attention on areas with near-term market applications. The combined effect of public and private funding dynamics, mediated through a publishing prestige system controlled by a small number of corporations, produces a research agenda that reflects neither the full range of American public need nor the organic curiosity-driven priorities of the scientific community itself.

Voices From the Margins of the Mainstream

Researchers working outside the dominant paradigms describe the experience in terms that are strikingly consistent. A public health investigator studying maternal mortality in rural Mississippi noted that her team's most significant findings were rejected by three major journals before landing in a respected but lower-impact publication—a placement that directly affected her department's ability to secure follow-on funding. A computational social scientist whose work examined algorithmic bias in credit markets described being advised by a senior colleague to reframe his research questions to align with the methodological preferences of a specific Elsevier journal before submitting grant applications.

These are not isolated anecdotes. They describe the routine operation of incentive structures that most working researchers navigate as a matter of professional survival. The system does not require bad actors; it requires only that rational people respond predictably to the incentives in front of them.

What Reform Looks Like—and Where It Stands

The open access movement has made meaningful progress in disrupting the subscription model that gives major publishers much of their leverage. Federal mandates requiring public access to federally funded research, most recently strengthened by the Biden administration's 2022 guidance from the Office of Science and Technology Policy, have accelerated the availability of research outside paywalls. Several major research universities have adopted policies that limit or refuse to pay for certain commercial journal subscriptions, redirecting funds toward open-access infrastructure.

Yet access reform alone does not address the prestige problem. So long as tenure, promotion, and funding decisions rely on journal impact factors controlled by the same commercial publishers, the structural incentives shaping research agendas remain largely intact. More fundamental reform would require decoupling professional evaluation from commercial prestige metrics—a shift that is beginning to gain traction in some European research systems but remains nascent in the United States.

Alternative evaluation frameworks, including open peer review, post-publication citation analysis, and direct assessment of societal impact, are under active development across several US research institutions. Whether they achieve sufficient institutional adoption to meaningfully redistribute research attention remains an open question.

The Stakes for American Science

The concentration of publishing power in a small number of commercial hands is not an abstract governance problem. It is a practical constraint on the breadth and equity of American scientific knowledge. Research gaps in underserved fields are not merely inconvenient; they represent real deficits in the evidence base available to policymakers, clinicians, educators, and communities making consequential decisions.

For researchers, students, and practitioners seeking to access and evaluate the full range of available evidence, understanding how the publishing landscape shapes what exists—and what does not—is an essential form of research literacy. The papers that never got written, the questions that never received sustained investigation, the communities whose health and welfare never attracted the research attention proportionate to their need: these absences are as much a product of publishing market structure as any deliberate policy choice.

FreePaperDownload exists, in part, because the current system fails to make knowledge freely available to those who need it. But the deeper challenge is ensuring that the knowledge being produced in the first place reflects the full scope of human inquiry—not just the questions that happen to be profitable to publish.